{"database": "openregs", "table": "federal_register", "rows": [["2025-22249", "Product-Specific Guidance on Estradiol; Draft Guidance for Industry; Availability", "Notice", "The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a new draft guidance for industry entitled \"Draft Guidance on Estradiol\" and a revised draft guidance for industry entitled \"Draft Guidance on Estradiol.\" The new draft guidance and the revised draft guidance, when finalized, will provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for estradiol vaginal inserts and estradiol vaginal tablets.", "2025-12-08", 2025, 12, "https://www.federalregister.gov/documents/2025/12/08/2025-22249/product-specific-guidance-on-estradiol-draft-guidance-for-industry-availability", "https://www.govinfo.gov/content/pkg/FR-2025-12-08/pdf/2025-22249.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a new draft guidance for industry entitled \"Draft Guidance on Estradiol\" and a revised draft guidance for industry entitled \"Draft Guidance on Estradiol.\" The new...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2025-22249"], "units": {}, "query_ms": 0.7449999684467912, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}